当前位置: 首页 > 期刊 > 《国际神经病学神经外科学杂志》 > 2004年第9期 > 正文
编号:11354932
Optic chiasm enhancement associated with giant aneurysm and yttrium treated pituitary adenoma
http://www.100md.com 《神经病学神经外科学杂志》
     1 Department of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1, UK

    2 Department of Ophthalmology, National Hospital for Neurology and Neurosurgery

    3 Department of Neuroradiology, National Hospital for Neurology and Neurosurgery

    Correspondence to:

    Dr C M Gabriel

    Department of Neurology, St Mary’s Hospital, Praed St, London W2 1NY; carolyn.gabriel@St-Marys.nhs.uk

    ABSTRACT

    A patient with a history of pituitary tumour treated with yttrium 29 years before presented with an asymmetrical chiasmal neuropathy. Magnetic resonance imaging showed a partially thrombosed giant aneurysm of the right internal carotid artery, with enhancement of the chiasm and right optic tract adjacent to the aneurysm. It was thought that, in addition to the effects of compression, a peri-aneurysmal inflammatory reaction had developed, causing breakdown of the blood–brain barrier and consequent inflammatory changes in the optic chiasm. High dose steroid treatment led to significant improvement in vision within two weeks. Steroids may have a role in the acute preservation of vision in similar cases, as well as in cases of deterioration following coiling or embolisation of aneurysms where thrombosis within the aneurysm has been induced.

    Keywords: optic nerve disease; intracranial aneurysm

    CASE REPORT

    A 60 year old woman was admitted urgently with a four month history of gradual blurring of vision affecting the left eye. There was no pain and there were no other neurological problems.

    In 1974, the patient had been treated for a growth hormone secreting pituitary adenoma with yttrium implants and bromocriptine and had maintained low growth hormone levels since then. There was no visual compromise from the original tumour but we were not able to retrieve any neuro-ophthalmic assessment from that time. She was taking hydrocortisone as steroid replacement therapy and a diphosphonate for osteoporosis. She was also treated for hypertension and diabetes. In 1967 she had a mastectomy for breast cancer.

    On examination she had prognathism and prominent supraorbital ridges, characteristic of acromegaly. Corrected visual acuity was 6/6 on the right, with normal colour vision (Ishihara plates). On the left, acuity was 2/60 and she was only able to read the first (control) Ishihara plate when viewed in the nasal hemifield. Confrontational field testing with a light source showed a temporal hemianopia on the left, and Goldman perimetry showed a generally depressed field with temporal loss respecting the vertical meridian on the right. There was a left relative afferent pupillary defect. The optic discs appeared cupped, but red-free photography did not show corresponding loss of the retinal nerve fibre layer. Her eye movements were normal, as was the rest of the neurological examination, other than distal lower limb sensory loss. General examination was normal but for the previous mastectomy scar.

    Growth hormone and other pituitary hormones were normal and prolactin was not raised.

    MRI of head and orbits (fig 1) showed chiasmal displacement by a heterogeneous mass lesion, confirmed as a giant aneurysm of the right internal carotid artery by angiography. The mixed signal within the aneurysm represented partial thrombosis and slow or turbulent flow. The chiasm appeared thickened and both the chiasm and the right optic tract enhanced with gadolinium.

    Figure 1 MRI of the brain. A heterogeneous signal intensity sella and suprasellar lesion is shown. The optic chiasm is displaced superiorly and draped over the suprasellar component. The chiasm and proximal right optic tract are of high signal on FLAIR (A) and enhance with gadolinium on T1 (B and C).

    As the appearance was compatible with breakdown of the blood–brain barrier in the anterior visual pathway, we supposed that in addition to the effects of compression, the aneurysm may have generated an inflammatory reaction in the adjacent chiasm. The lack of gross evidence for optic atrophy was also compatible with there being a potentially reversible cause of visual impairment. The patient was treated with high dose intravenous methylprednisolone (1 g/day for three days), then oral prednisolone tapering from 40 mg/day to zero over two weeks. After two weeks there was improvement in vision, with acuity on the left improving to 6/18 and substantial improvement in both visual fields (fig 2). There was no deterioration in either acuity or visual fields when steroids were discontinued.

    Figure 2 Visual fields before and after steroid treatment.

    Because of the risk of further damage to the visual pathways we proceeded to definitive treatment of the aneurysm. Following a successful carotid test occlusion, the patient proceeded to trapping of the right internal carotid artery aneurysm with proximal and distal balloons. She developed a right Horner’s syndrome and delayed mild left hemiparesis after becoming hypotensive several days post-procedure. Her left eye acuity improved further to 6/9. She was not given further steroids and her vision has remained stable eight months later.

    DISCUSSION

    The high signal and enhancement of the chiasm and optic tract and the response to steroids in our patient make an inflammatory chiasmal neuropathy the most likely explanation for her visual symptoms. There have been no other reports of reversible inflammatory lesions of the anterior visual pathway linked to internal carotid aneurysms other than in association with muslin wrapping.1

    Various mechanisms may be postulated to explain the chiasmal inflammation. These include a direct effect of chiasmal displacement (mass effect), ischaemia from compression of the blood supply to the chiasm, radiation damage, and an inflammatory reaction around the thrombosed aneurysm.

    Optic tract oedema manifesting as high signal on magnetic resonance imaging has been reported in association with intracranial tumours,2–5 but compression alone seems an unlikely cause of this, and additional mechanisms have been postulated such as tumour related cytokines3 and physical obstruction to drainage of Virchow-Robin spaces.5 Certainly, the oedema does not appear to be related to compression per se as it is not seen with the commonest cause of chiasmal compression, pituitary adenoma (personal observation). Thrombosis of an aneurysm, either spontaneous6,7 or following treatment,8,9 may cause neurological deterioration probably because of an increase in aneurysm size,10 and this was a possible cause of deterioration in our patient.

    The time elapsed since maximum irradiation from yttrium in this case, and the response to steroids, make a radiation induced optic neuropathy unlikely, although it is probable that the aneurysm itself was a secondary effect of radiation. Damage to the carotid arteries by yttrium implants was noted half a century ago11 and aneurysms of the cavernous internal carotid artery are now well recognised, though rare.12,13

    Intra-aneurysmal thrombosis may have induced perianeurysmal inflammation. Vasoactive factors such as vascular endothelial growth factor (VEGF) are released during platelet aggregation14 and have an active role in endothelial permeability; corticosteroids have been shown to reduce the release of VEGF.9

    Whether the visual deterioration and enhancing optic chiasm and tract in our case reflected compression or perianeurysmal inflammation, there was a clear response to steroids. Although susceptibility to such pathology in our patient may have been modified by long standing radiation effects on the chiasm, anti-inflammatory treatment could play a role in the acute preservation of vision in similar circumstances. This might also apply to acute deterioration occurring during the monitoring of known giant aneurysms, and extend to deterioration following coiling or embolisation of aneurysms, where thrombosis within the aneurysm has been induced.

    REFERENCES

    Bhatti M T, Holder C A, Newman N J, et al. MR Characteristics of muslin-induced optic neuropathy: report of two cases and review of the literature. Am J Neuroradiol 2000;21:346–52.

    Youl B D, Plant G T P, Stevens J M, et al. Three cases of craniopharyngioma showing optic tract hypersignal on MRI. Neurology 1990;40:1416–19.

    Sklar E M, Schaz N J, Glaser J S, et al. Optic tract edema in a meningioma of the tuberculum sellae. Am J Neuroradiol 2000;21:1661–3.

    Saeki N, Murai H, Kubota M, et al. Oedema along the optic tract due to pituitary metastasis. Br J Neurosurg 2001;15:523–6.

    Saeki N, Uchino Y, Murai H, et al. MR imaging study of edema-like change along the optic tract in patients with pituitary region tumours. Am J Neuroradiol 2003;24:336–42.

    Miller N R, Savino P J, Schneider T. Rapid growth of an intracranial aneurysm causing apparent retrobulbar optic neuritis. J Neuroopthalmol 1995;15:212–18.

    Aoki N. Partially thrombosed aneurysm presenting as the sudden onset of bitemporal hemianopia. Neurosurgery 1988;22:564–6.

    Litofsky N S, Vinuela F, Giannotta S L. Progressive visual loss after electrothrombosis treatment of a giant intracranial aneurysm: Case report. Neurosurgery 1995;34:548–51.

    Blanc R, Weill A, Piotin M, et al. Delayed stroke secondary to increasing mass effect after endovascular treatment of a giant aneurysm by parent vessel occlusion. Am J Neuroradiol 2001;22:841–3.

    Heros R C. Partially thrombosed aneurysm presenting as the sudden onset of bitemporal hemianopsia. Neurosurgery 1988;22:566.

    Rasmussen T, Harper P V, Kennedy T. The use of a beta ray point source for destruction of the hypophysis. Surg Forum 1953;4:681.

    Thun F, Lanfermann H. Intracranial giant aneurysms induced by irradiation. Radiologe 1991;31:244–6.

    McConachie N S, Jacobson I. Bilateral aneurysms of the cavernous internal carotid arteries following yttium-90 implantation. Neuroradiology 1994;36:611–13.

    Maloney J P, Silliman C C, Ambruso D R, et al. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998;275:H1054–61.(C M Gabriel1, J C Stevens)